I agree that this site is using cookies. You can find further informations here.
X
Al-Samkari, H
137  results:
Search for persons X
?
1

PB1314 Risk Assessing Medical Inpatients for Bleeding Event..:

Al-Samkari, H. ; Wilkinson, K. ; Roetker, N....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101233 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOU..:

Kuo, K ; Layton, D ; Al-Samkari, H...
HemaSphere.  6 (2022)  - p. 23-24 , 2022
Link: https://doi.org/10.1097/..
 
?
3

P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIV..:

Kuo, K. H. ; Grace, R. F. ; van Beers, E. J....
HemaSphere.  6 (2022)  - p. 1616-1617 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P1544: BONE MINERAL DENSITY REMAINS STABLE IN PYRUVATE KINA..:

Al-Samkari, H. ; Grace, R. F. ; Glenthøj, A....
HemaSphere.  6 (2022)  - p. 1425-1426 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P1548: LONG-TERM TREATMENT WITH ORAL MITAPIVAT IS ASSOCIATE..:

Barcellini, W. ; Grace, R. F. ; Al-Samkari, H....
HemaSphere.  6 (2022)  - p. 1429-1430 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P1522: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE K..:

Kuo, K. H. M. ; Layton, D. M. ; Lal, A....
HemaSphere.  6 (2022)  - p. 1403-1404 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND RE..:

van Beers, E. J. ; Al-Samkari, H. ; Grace, R. F....
HemaSphere.  6 (2022)  - p. 1446-1447 , 2022
Link: https://doi.org/10.1097/..
 
?
8

LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE A..:

Kuo, KH ; Layton, DM ; Lal, A...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S11-S12 , 2022
Link: https://doi.org/10.1016/..
 
?
9

S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KI..:

Kuo, K ; Layton, D ; Lal, A...
HemaSphere.  6 (2022)  - p. 8-9 , 2022
Link: https://doi.org/10.1097/..
 
?
10

P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECOND..:

Al-Samkari, H. ; Morales-Arias, J. ; Xu, R...
HemaSphere.  6 (2022)  - p. 1424-1425 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN T..:

Grace, R. F. ; Glenthøj, A. ; Barcellini, W....
HemaSphere.  6 (2022)  - p. 1426-1427 , 2022
Link: https://doi.org/10.1097/..
 
?
12

RESULTS FROM A PHASE 2 STUDY OF MITAPIVAT IN ADULTS WITH NO..:

Kuo, KH ; Layton, DM ; Lal, A...
Hematology, Transfusion and Cell Therapy.  43 (2021)  - p. S28 , 2021
Link: https://doi.org/10.1016/..
 
?
13

ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BL..:

Kuo, KH ; Layton, DM ; Al-Samkari, H...
Hematology, Transfusion and Cell Therapy.  43 (2021)  - p. S20 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Cancer and thrombosis: new insights to an old problem:

Leiva, O. ; Newcomb, R. ; Connors, J.M..
JMV-Journal de Médecine Vasculaire.  45 (2020)  6 - p. 6S8-6S16 , 2020
Link: https://doi.org/10.1016/..
 
?
15

WS01.6 Antifibrinolytics therapy for treatment of hemoptysi..:

Cardoni, L. ; Perkins, R. ; Shin, K....
Journal of Cystic Fibrosis.  19 (2020)  - p. S2 , 2020
Link: https://doi.org/10.1016/..
 
1-15